Autologous Fecal Microbiota Transplantation
Sponsors
MaaT Pharma, Rambam Health Care Campus, Medical University of Graz, Madhusudan (Madhu) Grover, MBBS, Peking University People's Hospital
Conditions
DiarrheaDiversion ColitisFecal IncontinenceFecal Microbiota TransplantationFecal Microbiota Transplantation in Graft vs. Host DiseaseGut Microbiota DysbiosisIleostomyIrritable Bowel Syndrome
Phase 1
Phase 2
Unknown Phase
Autologous Fecal Microbiota Transplantation for Patients With Acute Graft-versus-Host Disease
WithdrawnNCT03492502
Start: 2019-08-01End: 2020-03-05Updated: 2020-03-11
The IRMI-FMT Trial
TerminatedNCT04577729
Start: 2021-05-21End: 2023-06-07Updated: 2023-07-10
Autologous Fecal Microbiota Transplantation for Anal Function Recovery After Ileostomy Reversal in Rectal Cancer
Active, not recruitingNCT07711509
Start: 2025-03-25End: 2026-09-01Updated: 2026-07-17